These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 10482924)

  • 1. Pharmacological characterization of ATP- and LPS-induced IL-1beta release in human monocytes.
    Grahames CB; Michel AD; Chessell IP; Humphrey PP
    Br J Pharmacol; 1999 Aug; 127(8):1915-21. PubMed ID: 10482924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGF-β1 prevents up-regulation of the P2X7 receptor by IFN-γ and LPS in leukemic THP-1 monocytes.
    Gadeock S; Tran JN; Georgiou JG; Jalilian I; Taylor RM; Wiley JS; Sluyter R
    Biochim Biophys Acta; 2010 Nov; 1798(11):2058-66. PubMed ID: 20670615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1 beta processing and release.
    Elssner A; Duncan M; Gavrilin M; Wewers MD
    J Immunol; 2004 Apr; 172(8):4987-94. PubMed ID: 15067080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonist effects on human P2X(7) receptor-mediated cellular accumulation of YO-PRO-1.
    Michel AD; Kaur R; Chessell IP; Humphrey PP
    Br J Pharmacol; 2000 Jun; 130(3):513-20. PubMed ID: 10821778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitogen-activated protein kinase and caspase signaling pathways are required for P2X7 receptor (P2X7R)-induced pore formation in human THP-1 cells.
    Donnelly-Roberts DL; Namovic MT; Faltynek CR; Jarvis MF
    J Pharmacol Exp Ther; 2004 Mar; 308(3):1053-61. PubMed ID: 14634045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complexities of measuring antagonist potency at P2X(7) receptor orthologs.
    Hibell AD; Thompson KM; Xing M; Humphrey PP; Michel AD
    J Pharmacol Exp Ther; 2001 Mar; 296(3):947-57. PubMed ID: 11181928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glu496 to Ala polymorphism in the P2X7 receptor impairs ATP-induced IL-1 beta release from human monocytes.
    Sluyter R; Shemon AN; Wiley JS
    J Immunol; 2004 Mar; 172(6):3399-405. PubMed ID: 15004138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological characterization of P2X7 receptors in rat peritoneal cells.
    Chen YW; Donnelly-Roberts DL; Namovic MT; Gintant GA; Cox BF; Jarvis MF; Harris RR
    Inflamm Res; 2005 Mar; 54(3):119-26. PubMed ID: 15883745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional characterization of the P2X(4) receptor orthologues.
    Jones CA; Chessell IP; Simon J; Barnard EA; Miller KJ; Michel AD; Humphrey PP
    Br J Pharmacol; 2000 Jan; 129(2):388-94. PubMed ID: 10694247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterization of the P2X(7) receptor on human macrophages using the patch-clamp technique.
    Eschke D; Wüst M; Hauschildt S; Nieber K
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):168-71. PubMed ID: 11819036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATP-stimulated release of interleukin (IL)-1beta and IL-18 requires priming by lipopolysaccharide and is independent of caspase-1 cleavage.
    Mehta VB; Hart J; Wewers MD
    J Biol Chem; 2001 Feb; 276(6):3820-6. PubMed ID: 11056157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Essential role for Ca2+ in regulation of IL-1beta secretion by P2X7 nucleotide receptor in monocytes, macrophages, and HEK-293 cells.
    Gudipaty L; Munetz J; Verhoef PA; Dubyak GR
    Am J Physiol Cell Physiol; 2003 Aug; 285(2):C286-99. PubMed ID: 12660148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of ATP-induced current through P2X7 receptor in NG108-15 cells: unique antagonist sensitivity and lack of pore formation.
    Watano T; Matsuoka I; Kimura J
    Jpn J Pharmacol; 2002 Apr; 88(4):428-35. PubMed ID: 12046986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purinergic receptor modulation of lipopolysaccharide signaling and inducible nitric-oxide synthase expression in RAW 264.7 macrophages.
    Hu Y; Fisette PL; Denlinger LC; Guadarrama AG; Sommer JA; Proctor RA; Bertics PJ
    J Biol Chem; 1998 Oct; 273(42):27170-5. PubMed ID: 9765236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular ATP induces P2X7-dependent nicotinamide phosphoribosyltransferase release in LPS-activated human monocytes.
    Schilling E; Hauschildt S
    Innate Immun; 2012 Oct; 18(5):738-44. PubMed ID: 22377803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological activity of N-arylpiperazine-modified analogues of KN-62, a potent antagonist of the purinergic P2X7 receptor.
    Baraldi PG; del Carmen Nuñez M; Morelli A; Falzoni S; Di Virgilio F; Romagnoli R
    J Med Chem; 2003 Apr; 46(8):1318-29. PubMed ID: 12672232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid ATP-induced release of matrix metalloproteinase 9 is mediated by the P2X7 receptor.
    Gu BJ; Wiley JS
    Blood; 2006 Jun; 107(12):4946-53. PubMed ID: 16514055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a selective and potent antagonist of human P2X(7) receptors, AZ11645373.
    Stokes L; Jiang LH; Alcaraz L; Bent J; Bowers K; Fagura M; Furber M; Mortimore M; Lawson M; Theaker J; Laurent C; Braddock M; Surprenant A
    Br J Pharmacol; 2006 Dec; 149(7):880-7. PubMed ID: 17031385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P2X7-dependent release of interleukin-1beta and nociception in the spinal cord following lipopolysaccharide.
    Clark AK; Staniland AA; Marchand F; Kaan TK; McMahon SB; Malcangio M
    J Neurosci; 2010 Jan; 30(2):573-82. PubMed ID: 20071520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P2X7 receptor-dependent blebbing and the activation of Rho-effector kinases, caspases, and IL-1 beta release.
    Verhoef PA; Estacion M; Schilling W; Dubyak GR
    J Immunol; 2003 Jun; 170(11):5728-38. PubMed ID: 12759456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.